Support research to identify effective treatment options and find a cure for Gliomatosis Cerebri is one of the main objectives of the GC Global Community. We also aim for collaboration with physicians and researchers to support international Gliomatosis Cerebri conferences to raise awareness and advance research. Read about updates on ongoing research and projects from partners we help fund or collaborate with.
Weill Cornell – Brain and Spine Center
Image Source: Weil Cornell Medicine Brain and Spine
Weill Cornell Medicine is a research partner for the Gliomatosiscerebri.org. They are an active participant in the GC-Conference. They are committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world.
Since 1898, their doctors and scientists have been engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Weill Cornell Medicine’s powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria, and Turkey.
Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist.
Click on the links below to know more about Weil Cornell’s research involvement with Gliomatosis Cerebri
Join the advocacy and become part of the community that was established to support groundbreaking research in finding a cure for Gliomatosis Cerebri. Partners are either family touched by Gliomatosis Cerebri or foundations supporting the same cause. Click below to learn how to join the community.
Share4Rare is a European project which aims to improve the quality of life of those affected by a rare disease. Their vision is to improve patients' lives by promoting better science. Currently, they partner with several research institutions in the UK and now with the Gliomatosis Cerebri Conference to advance research and share knowledge.